| Name | EC5026 |
|---|
| Description | EC5026 (BPN-19186) is a first-in-class, potent and orally active soluble Epoxide Hydrolase (sEH) inhibitor. EC5026 has the potential to relieve pain by stabilizing natural analgesic and anti-inflammatory mediators[1]. |
|---|---|
| Related Catalog | |
| In Vivo | EC5026 (BPN-19186) has already shown efficacy for treating pain with no apparent adverse or addictive effects in laboratory animals and relieving naturally occurring pain in dogs, cats and horses[1]. |
| References |
| Molecular Formula | C18H23F4N3O3 |
|---|---|
| Molecular Weight | 405.39 |